RICHARTZ et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al
PAUL RICHARTZ and LINDA RICHARTZ |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM USA CORPORATION, PFIZER INC., GLAXOSMITHKLINE LLC, GLAXOSMITHKLINE (AMERICA) INC., GLAXOSMITHKLINE PLC, PATHEON MANUFACTURING SERVICES LLC, L. PERRIGO CO., PERRIGO COMPANY, PERRIGO RESEARCH & DEVELOPMENT COMPANY, DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES LLC |
3:2023cv03584 |
July 5, 2023 |
US District Court for the District of New Jersey |
Douglas E Arpert |
Michael A Shipp |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1441 Notice of Removal- Product Liability |
Plaintiff |
Docket Report
This docket was last retrieved on August 4, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 5 Order of MDL Panel (CTO-118) transferring case to the Southern District of Florida. (jjc, ) |
Case electronically transferred to the USDC for the Southern District of Florida. (jjc, ) |
Case transferred from New Jersey has been opened in Southern District of Florida as case 9:23-cv-81118. (mg) |
Filing 4 NOTICE of Appearance by VINCENT CHENG on behalf of All Plaintiffs (CHENG, VINCENT) |
CLERK'S QUALITY CONTROL MESSAGE - The case you electronically filed has been processed, however, the following deficiencies were found: All defendants were not added to the docket. When entering parties make sure to add ALL PLAINTIFFS AND DEFENDANTS as found on the original state court complaint. The Clerk's Office has made the appropriate changes. Please refer to the Attorney Case Opening Guide for processing electronically filed cases. (jjc, ) |
CLERK'S QUALITY CONTROL MESSAGE - Please be advised, pursuant to Fed. R. Civ. P. 7.1, a disclosure statement is required to be filed by parties and intervenors in diversity actions to identify the citizenship of every individual or entity whose citizenship is attributed to that party or intervenor. Such disclosure statements must be filed with the parties, intervenors or proposed intervenors first appearance, pleading, petition, motion, response or other request addressed to the Court. (kht) |
Judge Michael A. Shipp and Magistrate Judge Douglas E. Arpert added. (kht) |
Filing 3 NOTICE of Appearance by TIMOTHY IGNATIUS DUFFY on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation (DUFFY, TIMOTHY) |
Filing 2 Corporate Disclosure Statement by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (SILVER, MARK) |
Filing 1 NOTICE OF REMOVAL by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation from Superior Court of New Jersey, Middlesex County, case number MID-L-005126-22. ( Filing and Admin fee $ 402 receipt number ANJDC-14431501), filed by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3 - Part 1, #4 Exhibit 3 - Part 2, #5 Exhibit 3 - Part 3, #6 Exhibit 3 - Part 4, #7 Exhibit 3 - Part 5, #8 Civil Cover Sheet)(SILVER, MARK) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.